Shockwave Medical, Inc.
SWAV
$330.00
-$0.38-0.12%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 26.64% | 21.22% | -26.23% | -72.23% | 302.57% |
| Total Depreciation and Amortization | 2.19% | 17.26% | 50.23% | 11.05% | 22.26% |
| Total Amortization of Deferred Charges | 91.30% | 1,311.43% | 6.06% | -45.00% | -63.19% |
| Total Other Non-Cash Items | -33.27% | 37.48% | 26.94% | 118.37% | -719.78% |
| Change in Net Operating Assets | 134.65% | -30.65% | 48.78% | -332.67% | 66.73% |
| Cash from Operations | 41.56% | 27.47% | 17.00% | -35.23% | 52.04% |
| Capital Expenditure | -24.21% | 25.26% | -21.70% | 35.13% | -54.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.78% | -1,643.71% | 45.03% | 155.26% | -1,386.28% |
| Cash from Investing | 20.80% | -265.15% | -1,455.03% | 117.52% | -568.61% |
| Total Debt Issued | -100.05% | -- | -100.00% | 231.00% | -- |
| Total Debt Repaid | 100.00% | 68.75% | -- | -- | -461.67% |
| Issuance of Common Stock | -94.66% | 792.56% | -88.19% | 283.37% | -71.59% |
| Repurchase of Common Stock | 94.12% | -750.00% | -33.33% | 82.35% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -493.44% | -- | -- | -- |
| Cash from Financing | -100.03% | 739.60% | -214.90% | 769.21% | 2,405.48% |
| Foreign Exchange rate Adjustments | 242.30% | -140.06% | -140.66% | -50.56% | 230.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -147.51% | 354.64% | -212.75% | 338.48% | -0.03% |
